You just read:

Clementia Pharmaceuticals Expands Ongoing Phase 2 Study to Include Children with Fibrodysplasia Ossificans Progressiva (FOP)

News provided by

Clementia Pharmaceuticals, Inc.

25 Aug, 2015, 13:00 BST